- HALO has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $22.7 million.
- HALO has traded 97,770 shares today.
- HALO is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in HALO with the Ticky from Trade-Ideas. See the FREE profile for HALO NOW at Trade-Ideas More details on HALO: Halozyme Therapeutics, Inc., a biotechnology company, researches, develops, and commercializes human enzymes. Currently there are 3 analysts that rate Halozyme Therapeutics a buy, 1 analyst rates it a sell, and none rate it a hold. The average volume for Halozyme Therapeutics has been 1.4 million shares per day over the past 30 days. Halozyme has a market cap of $2.2 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.57 and a short float of 14.8% with 12.45 days to cover. Shares are up 80.8% year-to-date as of the close of trading on Friday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.